Gut Flora Dependent Metabolism of Dietary Phosphatidylcholine and Cardiovascular Disease
Completed · Early Phase 1
Conditions studied: Nutrition
In brief
The purpose of this study is to see if intestinal bacteria plays a role in choline metabolism (a form of choline monitored in this study is called phosphatidylcholine, also known as lecithin). This study will help to determine if choline metabolism is affected by short-term antibiotic therapy, and/or can be altered by probiotic therapy (e.g. in the form of eating yogurt).
Key facts
- Study ID
- NCT01519310
- Run by
- The Cleveland Clinic
- People needed
- 4
- Starts
- 2010-04-01
- Expected to finish
- 2014-10-01
- Last updated by the study team
- 2016-03-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Men and women age 18 years or above.
- Able to provide informed consent and comply with study protocol
You may not qualify if…
- Significant chronic illness or end-organ dysfunction, including known history of heart failure, renal failure, pulmonary disease, or hematologic diseases.
- Active infection or received antibiotics within 2 months of study enrollment
- Use of OTC probiotic within past 2 months, or ingestion of yogurt within past month
- Chronic gastrointestinal disorders, or intolerance to probiotic therapy
- Allergies to eggs.
Where it is running
- Cleveland Clinic — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.